Publications

Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis

Bone Marrow Transplantation (2020) Yokoyama, Teshima et al

ASBMT 2018: The Role of S1PR1 Agonism in Thymus-Dependent T-Cell Regeneration and Graft-vs.-Tumor Activity Following Experimental Allogeneic Hematopoietic Stem Cell Transplantation

Vollmer, Krenger (2018)

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)

Patricia A. Taylor et al

Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic

Hematopoietic Stem Cell Transplantation, Smith & Gergely 2017

ASBMT 2018: The Role of S1PR1 Agonism in Thymus-Dependent Generation of Autoreactive T Cells during Experimental Acute Graft-vs.-Host Disease

Vollmer and Krenger

Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists

Frontz Pharmacol – Perez et al (2019)

GVHD prophylaxis with KRP203, a SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATOR, is safe and may have a potential to improve

Poster, Heim et al

S1P signaling: new therapies and opportunities F1000 Prime reports

Gonzales 2014

Contact Us

Priothera Ltd
88 Harcourt Street, Dublin 2, D02 DK18, Ireland

Priothera Ltd
88 Harcourt Street, Dublin 2,
D02 DK18, Ireland

Priothera SAS France
9 Rue du Temple, Saint Louis, 68300, France